Key facts
- This page summarizes Junli He's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Dec 2023, 14:04.
Junli He - 06 Dec 2023 Form 4 Insider Report for Harvard Apparatus Regenerative Technology, Inc. (HRGN)
- Reporting relationship
- CEO, Director
- Issuer ticker
- HRGN
- Reported as of
- 06 Dec 2023
- Net transaction value
- +$7,605
- SEC form
- 4
- Accepted by SEC
- 11 Dec 2023, 14:04:40 UTC
- Prior SEC filing
- 18 Sep 2023
- Next SEC filing
- 18 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Damasio, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Junli He filed Form 4 for Harvard Apparatus Regenerative Technology, Inc. (HRGN) on 11 Dec 2023.
Change
- Previous filing in this sequence was filed on 18 Sep 2023.
- Current net transaction value: +$7,605.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HRGN
transaction
Common Stock
Purchase
- Transaction value
- $7,605
- Shares
- +1,500
- Change %
- +0.61%
- Price
- $5.07*
- Shares after
- 249,400
- Date
- 06 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions from December 6, 2023 to December 8, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.